Nanomedx has developed a novel carbon-based nanoparticle which can be utilised for multiple clinical applications to address some of the most pressing challenges in modern medicine. The Nanomedx platform is built on the scientific discovery of Professor Steven Wise and his team at University of Sydn...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2021 (4 years)
Address:
CHARLES PERKINS CENTRE; UNIVERSITY OF SYDNEY; SYDNEY, NSW 2006, AU
LOW
spending power
